Massachusetts Financial Services CO Ideaya Biosciences, Inc. Transaction History

Massachusetts Financial Services CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$20.95 - $26.88 $1.89 Million - $2.42 Million	-90,199 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$17.26 - $27.08 $365,963 - $574,177	21,203 Added 30.73%	90,199 $2.3 Million
Q2 2021 Aug 13, 2021	BUY	$17.76 - $24.83 $10,496 - $14,674	591 Added 0.86%	68,996 $1.45 Million
Q1 2021 May 13, 2021	SELL	$13.48 - $23.77 $109,255 - $192,655	-8,105 Reduced 10.59%	68,405 $1.61 Million
Q4 2020 Feb 12, 2021	BUY	$12.17 - $17.52 $568,679 - $818,674	46,728 Added 156.9%	76,510 $1.07 Million
Q3 2020 Nov 12, 2020	BUY	$11.22 - $14.46 $334,154 - $430,647	29,782 New	29,782 $374,000

214

80.9M

69K

20K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.14B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.